Blood pressure, cognitive dysfunction, and dementia

Journal of the American Society of Hypertension

Volumn 1, Issue 2, 2007, Pages 135-144

  Eftekhari, Hossein ^a   Uretsky, Seth ^a   Messerli, Franz H ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

antihypertensive therapy; Blood pressure; cognition; dementia

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BENDROFLUMETHIAZIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CAPTOPRIL; CHLORTALIDONE; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; HYDROCHLOROTHIAZIDE; INDAPAMIDE; NITRENDIPINE; PERINDOPRIL; PLACEBO; VALSARTAN;

AGING; ALZHEIMER DISEASE; BLOOD PRESSURE; BRAIN PERFUSION; CASE CONTROL STUDY; CLINICAL TRIAL; COGNITIVE DEFECT; DEMENTIA; DISEASE COURSE; HUMAN; HYPERTENSION; HYPOTENSION; INCIDENCE; LONGITUDINAL STUDY; META ANALYSIS; MULTIINFARCT DEMENTIA; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; RISK REDUCTION; STROKE; SYSTEMATIC REVIEW;

EID: 34247860852     PISSN: 19331711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jash.2007.01.003     Document Type: Review

References (71)

1. Hebert L.E., Beckett L.A., Scherr P.A., et al. Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Dis Assoc Disord 15 (2001) 169-173
2. Fratiglioni L., De Ronchi D., and Aguero-Torres H. Worldwide prevalence and incidence of dementia. Drugs Aging 15 (1999) 365-375
3. Brookmeyer R., Gray S., and Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health 88 (1998) 1337-1342
4. Jorm A.F., and Jolley D. The incidence of dementia: a meta-analysis. Neurology 51 (1998) 728-733
5. Canadian Study of Health and Aging: study methods and prevalence of dementia. CMAJ 150 (1994) 899-913
6. Roman G.C., Tatemichi T.K., Erkinjuntti T., et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN international workshop. Neurology 43 (1993) 250-260
7. van Duijn C.M., Stijnen T., and Hofman A. Risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. Int J Epidemiol 20 suppl 2 (1991) 2-73
8. Launer L.J., Andersen K., Dewey M.E., et al. Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. Neurology 52 (1999) 78-84
9. Martin J. Age-related changes in vascular responses: a review. Mech Aging Dev 79 (1995) 71-114
10. Faraci F.M., and Heistad D.D. Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev 78 (1998) 53-97
11. Mooradian A.D. Central nervous system complications of diabetes mellitus: a perspective from the blood-brain barrier. Brain Res Rev 23 (1997) 210-218
12. Kalmijn S., van Boxtel M.P., Verschuren M.W., et al. Cigarette smoking and alcohol consumption in relation to cognitive performance in middle age. Am J Epidemiol 156 (2002) 936-944
13. Miller J.W., Green R., Mungas D.M., et al. Homocysteine, vitamin B6, and vascular disease in AD patients. Neurology 58 (2002) 1471-1475
14. Roman G.C. Vascular dementia prevention: a risk factor analysis. Cerebrovasc Dis 20 suppl 2 (2005) 91-100
15. Di Carlo A., Baldereschi M., Amaducci L., et al. Cognitive impairment without dementia in older people: prevalence, vascular risk factors, impact on disability. The Italian Longitudinal Study on Aging. J Am Geriatr Soc 48 (2000) 775-782
16. MacMahon S., Peto R., Cutler J., et al. Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335 (1990) 765-774
17. Miller V.T. Lacunar stroke: a reassessment. Arch Neurol 40 (1983) 129-134
18. Salerno J.A., Murphy D.G., Horwitz B., et al. Brain atrophy in hypertension: A volumetric magnetic resonance imaging study. Hypertension 20 (1992) 340-348
19. Sparks D.L., Scheff S.W., Liu H., et al. Increased incidence of neurofibrillary tangles (NFT) in nondemented individuals with hypertension. J Neurol Sci 131 (1995) 162-169
20. Petrovitch H., White L.R., Izmirilian G., et al. Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia Aging Study. Neurobiol Aging 21 (2000) 57-62
21. van Boxtel M.P., Gaillard C., Houx P.J., et al. Can the blood pressure predict cognitive task performance in a healthy population sample?. J Hypertens 15 (1997) 1069-1076
22. Budge M.M., de Jager C., Hogervorst E., et al. Oxford Project To Investigate Memory and Ageing (OPTIMA). Total plasma homocysteine, age, systolic blood pressure, and cognitive performance in older people. J Am Geriatr Soc 50 (2002) 2014-2018
23. Kuo H.K., et al. Effect of blood pressure on cognitive functions in elderly persons. J Gerontol A Biol Sci Med Sci 59 (2004) 1191-1194
24. Suhr J.A., Stewart J.C., and France C.R. The relationship between blood pressure and cognitive performance in the Third National Health and Nutrition Examination Survey (NHANES III). Psychosom Med 66 (2004) 291-297
25. Swan G.E., Carmelli D., and Larue A. Systolic blood pressure tracking over 25 to 30 years and cognitive performance in older adults. Stroke 29 (1998) 2334-2340
26. Launer L.J., Masaki K., Petrovitch H., et al. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA 274 (1995) 1846-1851
27. Knopman D., Boland L.L., Mosley T., et al., Atherosclerosis Risk in Communities (ARIC) Study Investigators. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 56 (2001) 42-48
28. Wu C., Zhou D., Wen C., et al. Relationship between blood pressure and Alzheimer's disease in Linxian County, China. Life Sci 72 (2003) 1125-1133
29. Bellew K.M., Pigeon J.G., Stang P.E., et al. Hypertension and the rate of cognitive decline in patients with dementia of the Alzheimer type. Alzheimer Dis Assoc Disord 18 (2004) 208-213
30. Richards S.S., Emsley C.L., Roberts J., et al. The association between vascular risk factor-mediating medications and cognition and dementia diagnosis in a community-based sample of African-Americans. J Am Geriatr Soc 48 (2000) 1035-1041
31. Hajjar I., Keown M., and Frost B. Antihypertensive agents for aging patients who are at risk for cognitive dysfunction. Curr Hypertens Rep 7 (2005) 466-473
32. Peila R., White L.R., Masaki K., et al. Reducing the risk of dementia. Efficacy of long-term treatment of hypertension. Stroke 37 (2006) 1165-1170
33. Hajjar I., Catoe H., Sixta S., et al. Cross-sectional and longitudinal association between antihypertensive medications and cognitive impairment in an elderly population. J Gerontol A Biol Sci Med Sci 60 (2005) 67-73
34. in't Veld B.A., Ruitenberg A., Hofman A., et al. Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiol Aging 22 (2001) 407-412
35. Khachaturian A.S., Zandi P.P., Lyketsos C.G., et al. Antihypertensive medication use and incident Alzheimer disease: the Cache County Study. Arch Neurol 63 (2006) 686-692
36. The Systolic Hypertension in the Elderly Program (SHEP) Cooperative Research Group. Rationale and design of a randomized clinical trial on prevention of stroke in isolated systolic hypertension. J Clin Epidemiol 41 (1988) 1197-1208
37. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 265 (1991) 3255-3264
38. Applegate W.B., Pressel S., Wittes J., et al. Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program. Arch Intern Med 154 (1994) 2154-2160
39. Di Bari M., Pahor M., Franse L.V., et al. Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial. Am J Epidemiol 153 (2001) 72-78
40. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 304 (1992) 405-412
41. Prince M.J., Bird A.S., Blizard R.A., et al. The cognitive function of older patients affected by antihypertensive treatment?. Results from 54 months of the Medical Research Council's trial of hypertension in older adults. BMJ 312 (1996) 801-805
42. Starr J.M., Whalley L.J., and Deary I.J. The effects of antihypertensive treatment on cognitive function: results from the HOPE study. J Am Geriatr Soc 44 (1996) 411-415
43. Tzourio C., Anderson C., Chapman N., et al., The PROGRESS Collaborative Group. Effect of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 163 (2003) 1069-1075
44. Lithell H., Hansson L., Skoog I., et al., SCOPE Study Group. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens 21 (2003) 875-886
45. Fogari R., Mugellini A., Zoppi A., et al. Effects of valsartan compared with enalapril on blood pressure and cognitive function in elderly patients with essential hypertension. Eur J Clin Pharmacol 59 (2004) 863-868 2004 Jan 28;[E-pub]
46. Fogari R., Mugellini A., Zoppi A., et al. Influence of losartan and atenolol on memory function in very elderly hypertensive patients. J Hum Hypertens 17 (2003) 781-785
47. Forette F., Seux M.L., Staessen J.A., et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 352 (1998) 1347-1351
48. Forette F., Seux M.L., Staessen J.A., et al., Systolic Hypertension in Europe Investigators. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med 162 (2002) 2046-2052
49. Hanon O., Pequignot R., Seux M.L., et al. Relationship between antihypertensive drug therapy and cognitive function in elderly hypertensive patients with memory complaints. J Hypertens 24 (2006) 2101-2107
50. McGuinness B., Todd S., Passmore P., et al. The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease (review). Cochrane Database Syst Rev 2 (2006) CD004034
51. Morris M.C., Scherr P.A., Hebert L.E., et al. The cross-sectional association between blood pressure and Alzheimer's disease in a biracial community population of older persons. J Gerontol A Biol Sci Med Sci 55 (2000) M130-M136
52. Verghese J., Lipton R.B., Hall C.B., et al. Low blood pressure and the risk of dementia in very old individuals. Neurology 61 (2003) 1667-1672
53. Guo Z., et al. Low blood pressure and dementia in elderly people: the Kungsholmen project. BMJ 312 (1996) 805-808
54. Landin K., Blennow K., Wallin A., et al. Low blood pressure and blood glucose levels in Alzheimer's disease. Evidence for a hypometabolic disorder?. Intern Med 233 (1993) 357-363
55. Elmstahl S., Petersson M., Lilja B., et al. Autonomic cardiovascular responses to tilting in patients with Alzheimer's disease and in healthy elderly women. Age Aging 21 (1992) 301-307
56. Waldstein S.R., Giggey P.P., Thayer J.F., et al. Nonlinear relations of blood pressure to cognitive function: the Baltimore Longitudinal Study of Aging. Hypertension 45 (2005) 374-379
57. Morris M.C., Scherr P.A., Hebert L.E., et al. Association between blood pressure and cognitive function in a biracial community population of older persons. Neuroepidemiology 21 (2002) 123-130
58. Glynn R.J., Beckett L.A., Hebert L.E., et al. Current and remote blood pressure and cognitive decline. JAMA 281 (1999) 438-445
59. Launer L.J. Demonstrating the case that AD is a vascular disease: epidemiologic evidence. Aging Res Rev 1 (2002) 61-77
60. De la Torre J.C. Is Alzheimer's disease a neurodegenerative or a vascular disorder?. Data, dogma, and dialectics, Lancet Neurol 3 (2004) 184-190
61. Esiri M.M., Nagy Z., Smith M.Z., et al. Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet 354 (1999) 919-920
62. Vermeer S.E., Prins N.D., den Heijer T., et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 348 (2003) 1215-1222
63. Sinforiani E., Curci R., Fancellu R., et al. Neuropsychological changes after carotid endarterectomy. Funct Neurol 16 (2001) 329-336
64. Lunn S., Crawley F., Harrison F.M., et al. Impact of carotid endarterectomy upon cognitive functioning: a systematic review of the literature. Cerebrovasc Dis 9 (1999) 74-81
65. Vagnucci A.H., and Li W.W. Alzheimer's disease and angiogenesis. Lancet 361 (2003) 605-608
66. Kalback W., Esh C., Castano E.M., et al. Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease. Neurol Res 26 (2004) 525-539
67. Franklin S.S., Gustin IV W., Wong N.D., et al. Hemodynamic patterns of age-related changes in blood pressure: the Framingham Heart Study. Circulation 96 (1997) 308-315
68. Arnett D.K., Boland L.L., Evans G.W., et al. Hypertension and arterial stiffness: the Atherosclerosis Risk in Communities Study. Am J Hypertens 13 (2000) 317-323
69. Hofman A., Breteler M.M., Bots M.L., et al. Atherosclerosis, apolipoprotein E and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 349 (1997) 151-154
70. Aliev G., Seyidova D., Neal M.L., et al. Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice. Ann NY Acad Sci 977 (2002) 45-46
71. De la Torre J.C., and Stefano G.B. Evidence that Alzheimer's disease is a microvascular disorder: role of constitutive nitric oxide. Brain Res Rev 34 (2000) 119-136